BibTex RIS Cite

EVALUATION OF CEREBRAL BLOOD FLOW VOLUME USING COLOR DUPLEX SONOGRAPHY IN PATIENTS WITH POLYCYSTIC OVARY SYNDROME

Year 2005, Volume: 2 Issue: 3, 91 - 95, 01.09.2005

Murat Acar Serhan Cevrioğlu Aylin Yücel Bumin Değirmenci Ramazan Albayrak Alpay Haktanır

Abstract

Aim: Polycystic ovary syndrome (PCOS), one of the commonest endocrinopathies in the human, is known to be associated with risk factors for cerebrovascular disease. The aim of this study was to determine whether there was a change in cerebral blood flow volume in PCOS. Methods: We reported 30 women with PCOS and 20 healthy women as control group. We detected internal carotid (ICA), vertebral artery (VA) and cerebral blood flow (CBF) volumes using color duplex sonography. Results: There were no significant differences between patients with PCOS and control group in CBF volumes or the bilateral sum of flow volumes in the ICA and VA. There was also no statistically significant correlation between sum of bilateral VA, ICA and CBFV with age in both groups. However bilateral mean velocity of VA was significantly lower in patients with PCOS compared to control group. Conclusion: It seems that although endocrine and metabolic abnormalities occur in patients with PCOS there are no abnormality of CBF volume in young patients. However, a further study with a wider age range is required. Keywords: Polycystic ovary syndrome, Color duplex sonography, cerebral blood flow volume

Keywords

-

References

  • Kelly CJ, Speirs A, Gould GW, Petrie JR, Lyall H, Connell JM. Altered vascular function in young women with polycystic ovary syndrome. J Clin Endocrinol Metab 2002;87:742-6
  • Franks S. Polycystic ovary syndrome. N Eng J Med 1995;333:853-61
  • Dunaif A. Insulin resistance and the polycystic ovary syndrome: mechanism and implications for pathogenesis. Endocr Rev 1997;18:774-800
  • Wild RA, Painter RC, Coulson PB, Carruth KB, Ranney GB. Lipoprotein lipid concentrations and cardiovascular risk in women with polycystic ovary syndrome. J Clin Endocrinol Metab 1985; 61:946-51
  • Reaven GM. Banting lecture 1988. Role of insulin resistance in human disease. Diabetes 1988;37:1595-607
  • Castelli WP. The triglyceride issue: a view from Framingham. Am Heart J 1986; 112:432-7
  • Lakhani K, Constantinovici N, Purcell WM, Fernando R, Hardiman P. Internal carotid artery haemodynamics in women with polycystic ovaries. Clin Sci 2000; 98:661-5
  • Pierpoint T, McKeigue PM, Isaacs AJ, Wild SH, Jacobs HS. Mortality of women with polycystic ovary syndrome at long- term follow-up. J Clin Epidemiol 1998; 51:581-6
  • Battaglia C, Artini PG, D’Ambrogio G, Allesandro D, Genazzani AD, Genazzani AR. The role of colour Doppler imaging in the diagnosis of polycystic ovary syndrome. Am J Obstet Gynecol 1995; 172:108-13
  • Prelevic GM, Beljic T, Balint-Peric L, Ginsburg J. Cardiac flow velocity in women with the polycystic ovary syndrome. Clin Endocrinol 1995;43:677- 81
  • Lakhani K, Seifalian AM, Hardiman P. Impaired carotid viscoelastic properties in women with polycystic ovaries. Circulation 2002;106:81-5
  • Lakhani K, Constantinovici N, Purcell WM, Fernando R, Hardiman P. Internal carotid-artery response to 5% carbon dioxide in women with polycystic ovaries. Lancet 2000;356:1166-7
  • Mather KJ, Verma S, Corenblum B, Anderson function despite insulin resistance in healthy women with the polycystic ovary syndrome. J Clin Endocrinol Metab 2000; 85:1851-6 endothelial
  • Conway GS, Agrawal R, Betteridge DJ, Jacobs HS. Risk factors for coronary heart disease in lean and obese women with the polycystic ovary syndrome. Clin Endocrinol 1992;37:119-25
  • Dahlgren E, Janson PO, Johansson S, Lapidus L, Oden A. Polycystic ovary syndrome and risk for myocardial infarction. Evaluated from a risk factor model based on a prospective population study of eomen. Acta Obstet Gynecol Scand 1992;71:599-604
  • Emoto M, Nishizawa Y, Kawagishi T, et al. Stiffness indexes beta of the common carotid and femoral arteries are associated with insulin resistance in NIDDM. Diabetes Care 1998;21:1178-82
  • Cleland SJ, Petrie JR, Ueda S, Elliott HL, Connell JM. Mechanisms and pathophysiolohical insulin’s vascular action. Curr Opin Endocrinol Diabetes 1998;5:217-22 of
  • Paradisi G, Steinberg HO, Hempfling A et al. Polycystic ovary syndrome is associated with endothelial dysfunction. Circulation 2001;103:1410-5
  • Lau TK, Wan D, Yim SF, Sanderson JE, Haines CJ. Prospective, randomized, controlled study of the effect of hormone replacement therapy on peripheral blood flow velocity in postmenopausal women. Fertil Steril 1998;70:284-8
  • Scheel P, Ruge C, Petruch UR, Schöning M. Color duplex measurement of cerebral blood flow volume in healthy adults. Stroke 2000;31:147-50
  • Acar M, Degirmenci B, Yucel A, Albayrak R, Haktanir A. An evaluation of internal carotid artery and cerebral blood flow volume using color duplex sonography in patients with vertebral artery hypoplasia, Eur J Radiol 2005;53(3):450-3
  • Seidel E, Eicke BM, Tettenborn B, Krummenauer F. Reference values for vertebral artery flow volume by duplex sonography in young and elderly adults. Stroke 1999;30:2692-6

EVALUATION OF CEREBRAL BLOOD FLOW VOLUME USING COLOR DUPLEX SONOGRAPHY IN PATIENTS WITH POLYCYSTIC OVARY SYNDROME

Year 2005, Volume: 2 Issue: 3, 91 - 95, 01.09.2005

Murat Acar Serhan Cevrioğlu Aylin Yücel Bumin Değirmenci Ramazan Albayrak Alpay Haktanır

Abstract

-

Keywords

-

References

  • Kelly CJ, Speirs A, Gould GW, Petrie JR, Lyall H, Connell JM. Altered vascular function in young women with polycystic ovary syndrome. J Clin Endocrinol Metab 2002;87:742-6
  • Franks S. Polycystic ovary syndrome. N Eng J Med 1995;333:853-61
  • Dunaif A. Insulin resistance and the polycystic ovary syndrome: mechanism and implications for pathogenesis. Endocr Rev 1997;18:774-800
  • Wild RA, Painter RC, Coulson PB, Carruth KB, Ranney GB. Lipoprotein lipid concentrations and cardiovascular risk in women with polycystic ovary syndrome. J Clin Endocrinol Metab 1985; 61:946-51
  • Reaven GM. Banting lecture 1988. Role of insulin resistance in human disease. Diabetes 1988;37:1595-607
  • Castelli WP. The triglyceride issue: a view from Framingham. Am Heart J 1986; 112:432-7
  • Lakhani K, Constantinovici N, Purcell WM, Fernando R, Hardiman P. Internal carotid artery haemodynamics in women with polycystic ovaries. Clin Sci 2000; 98:661-5
  • Pierpoint T, McKeigue PM, Isaacs AJ, Wild SH, Jacobs HS. Mortality of women with polycystic ovary syndrome at long- term follow-up. J Clin Epidemiol 1998; 51:581-6
  • Battaglia C, Artini PG, D’Ambrogio G, Allesandro D, Genazzani AD, Genazzani AR. The role of colour Doppler imaging in the diagnosis of polycystic ovary syndrome. Am J Obstet Gynecol 1995; 172:108-13
  • Prelevic GM, Beljic T, Balint-Peric L, Ginsburg J. Cardiac flow velocity in women with the polycystic ovary syndrome. Clin Endocrinol 1995;43:677- 81
  • Lakhani K, Seifalian AM, Hardiman P. Impaired carotid viscoelastic properties in women with polycystic ovaries. Circulation 2002;106:81-5
  • Lakhani K, Constantinovici N, Purcell WM, Fernando R, Hardiman P. Internal carotid-artery response to 5% carbon dioxide in women with polycystic ovaries. Lancet 2000;356:1166-7
  • Mather KJ, Verma S, Corenblum B, Anderson function despite insulin resistance in healthy women with the polycystic ovary syndrome. J Clin Endocrinol Metab 2000; 85:1851-6 endothelial
  • Conway GS, Agrawal R, Betteridge DJ, Jacobs HS. Risk factors for coronary heart disease in lean and obese women with the polycystic ovary syndrome. Clin Endocrinol 1992;37:119-25
  • Dahlgren E, Janson PO, Johansson S, Lapidus L, Oden A. Polycystic ovary syndrome and risk for myocardial infarction. Evaluated from a risk factor model based on a prospective population study of eomen. Acta Obstet Gynecol Scand 1992;71:599-604
  • Emoto M, Nishizawa Y, Kawagishi T, et al. Stiffness indexes beta of the common carotid and femoral arteries are associated with insulin resistance in NIDDM. Diabetes Care 1998;21:1178-82
  • Cleland SJ, Petrie JR, Ueda S, Elliott HL, Connell JM. Mechanisms and pathophysiolohical insulin’s vascular action. Curr Opin Endocrinol Diabetes 1998;5:217-22 of
  • Paradisi G, Steinberg HO, Hempfling A et al. Polycystic ovary syndrome is associated with endothelial dysfunction. Circulation 2001;103:1410-5
  • Lau TK, Wan D, Yim SF, Sanderson JE, Haines CJ. Prospective, randomized, controlled study of the effect of hormone replacement therapy on peripheral blood flow velocity in postmenopausal women. Fertil Steril 1998;70:284-8
  • Scheel P, Ruge C, Petruch UR, Schöning M. Color duplex measurement of cerebral blood flow volume in healthy adults. Stroke 2000;31:147-50
  • Acar M, Degirmenci B, Yucel A, Albayrak R, Haktanir A. An evaluation of internal carotid artery and cerebral blood flow volume using color duplex sonography in patients with vertebral artery hypoplasia, Eur J Radiol 2005;53(3):450-3
  • Seidel E, Eicke BM, Tettenborn B, Krummenauer F. Reference values for vertebral artery flow volume by duplex sonography in young and elderly adults. Stroke 1999;30:2692-6
There are 22 citations in total.

Details

Primary Language English
Journal Section Original Articles
Authors

Murat Acar This is me

Serhan Cevrioğlu This is me

Aylin Yücel This is me

Bumin Değirmenci This is me

Ramazan Albayrak This is me

Alpay Haktanır This is me

Publication Date September 1, 2005
Published in Issue Year 2005 Volume: 2 Issue: 3

Cite

APA Acar, M., Cevrioğlu, S., Yücel, A., Değirmenci, B., et al. (2005). EVALUATION OF CEREBRAL BLOOD FLOW VOLUME USING COLOR DUPLEX SONOGRAPHY IN PATIENTS WITH POLYCYSTIC OVARY SYNDROME. European Journal of General Medicine, 2(3), 91-95.
AMA Acar M, Cevrioğlu S, Yücel A, Değirmenci B, Albayrak R, Haktanır A. EVALUATION OF CEREBRAL BLOOD FLOW VOLUME USING COLOR DUPLEX SONOGRAPHY IN PATIENTS WITH POLYCYSTIC OVARY SYNDROME. European Journal of General Medicine. September 2005;2(3):91-95.
Chicago Acar, Murat, Serhan Cevrioğlu, Aylin Yücel, Bumin Değirmenci, Ramazan Albayrak, and Alpay Haktanır. “EVALUATION OF CEREBRAL BLOOD FLOW VOLUME USING COLOR DUPLEX SONOGRAPHY IN PATIENTS WITH POLYCYSTIC OVARY SYNDROME”. European Journal of General Medicine 2, no. 3 (September 2005): 91-95.
EndNote Acar M, Cevrioğlu S, Yücel A, Değirmenci B, Albayrak R, Haktanır A (September 1, 2005) EVALUATION OF CEREBRAL BLOOD FLOW VOLUME USING COLOR DUPLEX SONOGRAPHY IN PATIENTS WITH POLYCYSTIC OVARY SYNDROME. European Journal of General Medicine 2 3 91–95.
IEEE M. Acar, S. Cevrioğlu, A. Yücel, B. Değirmenci, R. Albayrak, and A. Haktanır, “EVALUATION OF CEREBRAL BLOOD FLOW VOLUME USING COLOR DUPLEX SONOGRAPHY IN PATIENTS WITH POLYCYSTIC OVARY SYNDROME”, European Journal of General Medicine, vol. 2, no. 3, pp. 91–95, 2005.
ISNAD Acar, Murat et al. “EVALUATION OF CEREBRAL BLOOD FLOW VOLUME USING COLOR DUPLEX SONOGRAPHY IN PATIENTS WITH POLYCYSTIC OVARY SYNDROME”. European Journal of General Medicine 2/3 (September 2005), 91-95.
JAMA Acar M, Cevrioğlu S, Yücel A, Değirmenci B, Albayrak R, Haktanır A. EVALUATION OF CEREBRAL BLOOD FLOW VOLUME USING COLOR DUPLEX SONOGRAPHY IN PATIENTS WITH POLYCYSTIC OVARY SYNDROME. European Journal of General Medicine. 2005;2:91–95.
MLA Acar, Murat et al. “EVALUATION OF CEREBRAL BLOOD FLOW VOLUME USING COLOR DUPLEX SONOGRAPHY IN PATIENTS WITH POLYCYSTIC OVARY SYNDROME”. European Journal of General Medicine, vol. 2, no. 3, 2005, pp. 91-95.
Vancouver Acar M, Cevrioğlu S, Yücel A, Değirmenci B, Albayrak R, Haktanır A. EVALUATION OF CEREBRAL BLOOD FLOW VOLUME USING COLOR DUPLEX SONOGRAPHY IN PATIENTS WITH POLYCYSTIC OVARY SYNDROME. European Journal of General Medicine. 2005;2(3):91-5.